MPH Health Care

Earnings Release • Nov 25, 2014

News Details

Corporate | 25 November 2014 12:00

MPH Mittelständische Pharma Holding AG: + 45 % profit growth in the first 9 months 2014

MPH Mittelständische Pharma Holding AG / Key word(s): 9-month figures/Quarter Results

25.11.2014 / 12:00

---

MPH Mittelständische Pharma Holding AG:

+ 45 % profit growth in the first 9 months 2014

In the first 9 months 2014 MPH Group achieved sales of EUR 163.80 million (Prior-year period: EUR 169.78 million). Net profit increased by 45 % to EUR 8.98 million (Prior-year period: EUR 6.18 million).

The business strategy of “making a contribution towards maintaining healthcare affordable” has paid off. In the healthcare market MPH AG is following this strategy with an attractive offer of drugs (HAEMATO AG) and medical services (M1 Med Beauty AG).

“The healthcare segment contributes an ever increasing share to the Group’s profit. This confirms the success of our strategy. We are confident that the contribution of M1 Med Beauty AG to the success of the Group will rise continuously by the further expansion. For the year 2015 the autonomous listing of the company in the Entry Standard of the Frankfurt stock exchange is considered”, says Dr. Christian Pahl, Member of the Management Board of MPH AG.

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments Pharma and Healthcare. The pharmaceutical sector makes a contribution towards cutting costs in the healthcare system with medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. The field of healthcare offers a variety of services for individual patient therapies, aesthetic surgeries and other medical treatments.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 42,813,842

Listed shares: ordinary shares

ISIN: DE000A0L1H32

WKN: A0L1H3

Stock symbol: 93M

Contact: Linda Reichelt

MPH Mittelständische Pharma Holding AG

Fasanenstraße 77

D-10623 Berlin

Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669

E-Mail: ir@mph-ag.de Web: www.mph-ag.de

---

25.11.2014 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	MPH Mittelständische Pharma Holding AG
	Fasanenstraße 77
	10623 Berlin
	Germany
Phone:	030 / 897 308 660
Fax:	030 / 897 308 669
E-mail:	info@mph-ag.de
Internet:	www.mph-ag.de
ISIN:	DE000A0L1H32
WKN:	A0L1H3
Listed:	Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard)

End of News	DGAP News-Service

- - -
299221  25.11.2014